Welcome to our dedicated page for International Flavors&Fragranc news (Ticker: IFF), a resource for investors and traders seeking the latest updates and insights on International Flavors&Fragranc stock.
International Flavors & Fragrances Inc. (IFF) (NYSE: IFF) generates a steady flow of news that reflects its role as a global leader in flavors, fragrances, food ingredients, health and biosciences. This news page aggregates company announcements, press releases and related coverage so readers can follow how IFF’s strategies, operations and governance evolve over time.
IFF’s news often highlights developments across its core segments—Taste, Health & Biosciences, Scent and Food Ingredients. Examples include updates on segment performance from quarterly earnings releases, commentary on market dynamics within these segments and information on productivity and margin initiatives. Investors and analysts can use these items to understand how the company’s segment-level trends contribute to overall performance.
Operational and technology-focused announcements are another key news category for IFF. Recent releases describe the implementation of the Colibri smart dosing robot at its Scent and Taste production plant in Chin Bee, Singapore, which is used to produce fragrance sample batches on demand, and the installation of a green hydrogen production facility at its Benicarló, Spain site to support sustainable fragrance ingredient manufacturing. News items also cover plans for new facilities, such as a scent creative center in Mumbai, India, designed to enhance fragrance innovation in that market.
Corporate governance, capital allocation and strategic partnerships feature prominently in IFF’s news flow. The company reports on board appointments, changes in committee assignments and amendments to its bylaws. It also announces dividends, share repurchase authorizations and collaborations, such as its strategic collaboration with BASF to develop next-generation enzyme technologies and biobased polymers. Bookmark this page to access a consolidated view of IFF’s latest publicly released information, from financial results to sustainability initiatives and board-level decisions.
IFF (NYSE: IFF) reported Q1 2026 results: net sales $2.74B (reported -4%; comparable currency neutral +3%), adjusted operating EBITDA $568M (margin 20.7%), and adjusted EPS ex amortization $1.25. Cash from operations was $257M and free cash flow $92M. The company reaffirmed full-year 2026 guidance: sales $10.5–10.8B and adjusted operating EBITDA $2.05–2.15B, and is running a disciplined sale process for its Food Ingredients business.
International Flavors & Fragrances (NYSE: IFF) said its Board declared a regular quarterly cash dividend of $0.40 per share, payable July 10, 2026 to shareholders of record as of June 18, 2026.
Contact details for media and investor relations were provided.
IFF (NYSE: IFF) will release first quarter 2026 earnings after market close on May 5, 2026. The management team will host a live webcast on May 6, 2026 at 9:00 a.m. ET to discuss results and outlook. Investors can access the webcast and slides at ir.iff.com; a replay will be available.
Contact details for media and investor relations were provided for follow-up.
International Flavors & Fragrances (NYSE: IFF) will showcase wellness-driven, sustainable scent and bioscience innovations at In-Cosmetics Global 2026, April 14–16 at Paris Expo Porte de Versailles. Highlights include METAMOOD™, METASLEEP™, LMR Active Essences, AURIST™ AGC, GENENCARE® exhibits, and a technical seminar on April 15.
Attendees can experience sensory bars, live sessions, and formulation demonstrations focused on emotional and physical wellness benefits and ecofriendly extraction and biotech-enabled ingredients.
IFF (NYSE: IFF) launched PureStrong™ on April 2, 2026, a probiotic formulated specifically for canine digestive health using a single targeted strain of Limosilactobacillus reuteri sourced from healthy dogs. According to the company, a controlled study showed improved digestive markers, firmer stools and better diet tolerance.
PureStrong™ is part of IFF’s HOWARU Pet portfolio and is developed for powders, capsules, tablets and sticks to address the growing $3.2 billion U.S. pet supplement market.
IFF (NYSE: IFF) announced that Food Standards Australia New Zealand has accepted a heart health claim for isolated soy protein, allowing products in Australia and New Zealand to link soy protein to healthy blood cholesterol levels.
Under the permission, foods delivering a daily intake of 20–25 grams of isolated soy protein, consumed as part of a balanced diet, may carry the claim. The approval follows multi‑year research and aligns Australia and New Zealand with 11 other countries recognizing the soy protein–heart health link.
IFF (NYSE: IFF) is expanding its Latin America capabilities with a new fermentation‑based enzyme production hub in Arroyito, Argentina, and a household care application laboratory at its Innovation Center in Brazil, announced March 10, 2026. These investments aim to improve local enzyme production, speed, reliability and regionally relevant solutions across brewing, animal nutrition, biofuels and home care.
The initiatives bring initial biological‑stage enzyme production to the region and enable faster formulation testing under real regional conditions, reinforcing IFF Health & Biosciences’ multi‑decade commitment to Latin American growth.
IFF (NYSE: IFF) declared a regular quarterly cash dividend of $0.40 per share, payable on April 10, 2026 to shareholders of record as of March 20, 2026.
This announcement confirms IFF's continued distribution policy and provides a specific payment timeline and record date for investors.
International Flavors & Fragrances (NYSE: IFF) announced on March 2, 2026 that it has completed the divestiture of its soy crush, concentrates and lecithin businesses to Bunge. The sale excludes IFF’s soy isolates, which the company retained. The announcement confirms transfer of those operations to Bunge.
This divestiture narrows IFF's scope in soy processing while keeping its isolates business within the firm.
IFF (NYSE: IFF) launched Tonka Bean CO₂ Absolute, a gourmand natural extract added to its Conscious Collection of 12 sustainable ingredients. Produced with renewable and recycled supercritical CO₂ at Aubrac, France, the extract claims a -34% cradle-to-gate carbon footprint versus traditional tonka absolute.
IFF cites low-temperature, solvent-free extraction that preserves volatiles and improves performance and cost efficiency. The announcement follows a €10 million expansion at the Grasse LMR Naturals site to boost capacity for naturals innovation.